Results 141 to 150 of about 15,000 (182)
Some of the next articles are maybe not open access.

Hemodynamic Effects of Recombinant Human Erythropoietin

Nephron, 1999
BUEMI, Michele   +4 more
openaire   +3 more sources

The use of recombinant human erythropoietin (rHuEpo) in humans.

Cancer surveys, 1990
Recombinant human erythropoietin (rHuEpo) has now been in clinical trials for over four years. rHuEpo has been shown to be nearly uniformly effective in correcting the anaemia of patients on haemodialysis or patients with progressive chronic renal failure not yet on dialysis.
J W, Adamson, J W, Eschbach
openaire   +2 more sources

The use of recombinant human erythropoietin in humans.

Ciba Foundation symposium, 1990
Recombinant human erythropoietin (rhEPO) has now been in clinical trials for over three years. It has been shown to be nearly uniformly effective in correcting the anaemia of patients on haemodialysis or patients with progressive chronic renal failure not yet on dialysis. Preliminary results indicate that rhEPO is effective in increasing the ability of
J W, Adamson, J W, Eschbach
openaire   +1 more source

Isoforms of Recombinant Human Erythropoietin

1992
Recombinant human erythropoietin (rHuEPO) has been made commercially available utilizing a variety of expression systems. Whereas the peptide backbones of these recombinant proteins can be expected to be identical, a polymorphism of these recombinant materials with distinct variations in biological and physicochemical properties is observed.
R. V. Battersby   +3 more
openaire   +1 more source

Perioperative recombinant human erythropoietin.

Surgery, 1989
The risks of transfusion-associated infectious disease have made increased efforts to avoid homologous transfusion imperative. Little attention has been focused on efforts to accelerate erythropoiesis as a method of reducing homologous blood use. Recombinant human erythropoietin (rHuEPO) has been shown to enhance erythropoiesis.
E A, Levine   +7 more
openaire   +1 more source

[From natural to recombinant human erythropoietin. Biotechnological production of recombinant human erythropoietin].

Nephron, 1989
Human erythropoietin (EPO), which occurs only in minute quantities in human plasma, has been isolated from urine of patients and purified to homogeneity. A partial amino acid sequence from tryptic digests of the purified protein was selected for oligodeoxynucleotide probe synthesis. These probes were used to isolate the EPO gene from a human gene bank.
openaire   +1 more source

Epoetin: human recombinant erythropoietin.

Clinical pharmacy, 1989
The chemistry, pharmacology, pharmacokinetics, clinical uses and efficacy, adverse effects, drug interactions, dosage and administration, and formulary considerations of epoetin are described. Erythropoietin, a glycoprotein hormone primarily synthesized in the kidney, is the chief regulator of red blood cell production.
K K, Flaharty, A M, Grimm, P H, Vlasses
openaire   +1 more source

PRODUCTION OF RECOMBINANT HUMAN ERYTHROPOIETIN

XII Международная конференция молодых ученых: биоинформатиков, биотехнологов, биофизиков, вирусологов, молекулярных биологов и специалистов фундаментальной медицины — 2025 : сб. тез.
There are a number of diseases, including cancer, viral diseases, and somatic diseases, which can lead to symptomatic anemia. One of the causes of secondary anemia is a decrease or complete cessation of erythropoietin synthesis, which makes hormone replacement therapy an important component of treatment. Currently, there is a need in Russia to obtain a
D.A. Filippova   +9 more
openaire   +1 more source

Recombinant Human Erythropoietin in Children with Cancer

Pediatric Hematology and Oncology, 1996
H, Tamary, Y L, Danon
openaire   +2 more sources

Home - About - Disclaimer - Privacy